Latest News & Updates

Breaking News

  • 1 minute ago

  • Vaibhavi M.

Roche Launches Cobas MPX-E Assay For Multi-Virus Blood Screening In CE-Mark Markets, Expands Diagnostic Portfolio
Breaking News
Novartis Reports Major Kidney Breakthrough As Fabhalta Shows Strong 2-Year Benefits In IgAN Trial

Simantini Singh Deo

Other trending news you may like to read

Roche Launches Cobas MPX-E Assay For Multi-Virus Blood Screening In CE-Mark Markets, Expands Diagnostic Portfolio

Roche launches cobas MPX-E assay for blood screening, detecting HIV-1, HIV-2 and hepatitis B, C, E with high sensitivity to improve donor safety and lab efficiency in CE-mark markets

Vaibhavi M.

Pharma Now

Novartis Reports Major Kidney Breakthrough As Fabhalta Shows Strong 2-Year Benefits In IgAN Trial

Novartis reports Fabhalta (iptacopan) shows sustained Phase III efficacy in IgA nephropathy, slowing eGFR decline, reducing kidney failure risk, and improving proteinuria over two years

Simantini Singh Deo

Pharma Now

Tonix Initiates Phase 1 Study Of TNX-1900 Targeting Trigeminal Neurovascular Activity

Tonix Pharmaceuticals initiates Phase 1 study of TNX-1900 intranasal oxytocin therapy to evaluate trigeminal neurovascular activity linked to migraine and craniofacial pain.

Vaibhavi M.

Pharma Now

ImmunityBio’s QUILT-2.005 Trial Meets Power Goals, No Additional Enrollment Needed, IDMC Confirms Adequate Power In Bladder Cancer Study

ImmunityBio confirms Phase 3 QUILT-2.005 trial of ANKTIVA with BCG in non-muscle-invasive bladder cancer is adequately powered, with no additional enrollment required.

Vaibhavi M.

Pharma Now